X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6123) 6123
Book Review (1195) 1195
Publication (281) 281
Magazine Article (20) 20
Book / eBook (10) 10
Book Chapter (9) 9
Conference Proceeding (4) 4
Paper (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (5695) 5695
humans (3953) 3953
male (3619) 3619
hypolipidemic agents - therapeutic use (2779) 2779
animals (2614) 2614
hypolipidemic agents - pharmacology (2033) 2033
female (1994) 1994
hypolipidemic agents - administration & dosage (1906) 1906
rats (1603) 1603
middle aged (1533) 1533
pharmacology & pharmacy (1313) 1313
cholesterol (1176) 1176
adult (1094) 1094
triglycerides - blood (1053) 1053
aged (1024) 1024
hyperlipidemias - drug therapy (1004) 1004
lipids - blood (886) 886
risk factors (865) 865
cholesterol - blood (860) 860
lipids (745) 745
mice (727) 727
hypolipidemic agents - adverse effects (674) 674
abridged index medicus (665) 665
treatment outcome (647) 647
atherosclerosis (641) 641
cholesterol, ldl - blood (618) 618
liver - drug effects (602) 602
cardiac & cardiovascular systems (569) 569
liver - metabolism (560) 560
rats, wistar (557) 557
drug therapy, combination (553) 553
cholesterol, hdl - blood (519) 519
statins (511) 511
dose-response relationship, drug (490) 490
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (469) 469
diabetes (465) 465
coronary-heart-disease (458) 458
dyslipidemias - drug therapy (448) 448
triglycerides (448) 448
medicine, general & internal (447) 447
hyperlipidemia (445) 445
metabolism (439) 439
rats, sprague-dawley (434) 434
chemistry, medicinal (427) 427
cardiovascular diseases - prevention & control (420) 420
hyperlipidemias - blood (412) 412
cardiovascular disease (407) 407
endocrinology & metabolism (402) 402
fenofibrate (398) 398
time factors (397) 397
research (393) 393
biochemistry & molecular biology (392) 392
drug therapy (390) 390
analysis (378) 378
plant extracts - pharmacology (378) 378
hypolipidemic agents - chemistry (370) 370
liver (370) 370
diet (364) 364
simvastatin (364) 364
hypercholesterolemia (361) 361
risk (358) 358
care and treatment (357) 357
administration, oral (355) 355
prevention (354) 354
health aspects (347) 347
hypercholesterolemia - drug therapy (340) 340
cardiovascular-disease (336) 336
hypoglycemic agents - pharmacology (330) 330
hypoglycemic agents - therapeutic use (328) 328
peripheral vascular disease (328) 328
double-blind method (327) 327
dyslipidemia (324) 324
low density lipoproteins (317) 317
blood glucose - metabolism (316) 316
oxidative stress (312) 312
nutrition & dietetics (309) 309
fenofibrate - therapeutic use (304) 304
lipoproteins (302) 302
lipid metabolism (294) 294
disease (293) 293
therapy (292) 292
fenofibrate - administration & dosage (289) 289
disease models, animal (288) 288
insulin resistance (288) 288
hypolipidemic agents - pharmacokinetics (287) 287
glucose (286) 286
anticholesteremic agents (278) 278
diabetes mellitus, type 2 - drug therapy (278) 278
phytotherapy (278) 278
obesity (270) 270
clinical trials as topic (266) 266
myocardial-infarction (263) 263
diabetes mellitus, experimental - drug therapy (261) 261
lipid metabolism - drug effects (261) 261
insulin-resistance (259) 259
physiological aspects (255) 255
metabolic syndrome (246) 246
fenofibrate - pharmacology (244) 244
medicine & public health (244) 244
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (243) 243
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5646) 5646
German (109) 109
Russian (97) 97
French (48) 48
Spanish (47) 47
Chinese (40) 40
Japanese (29) 29
Italian (23) 23
Swedish (20) 20
Hungarian (19) 19
Danish (17) 17
Norwegian (17) 17
Polish (15) 15
Czech (14) 14
Ukrainian (6) 6
Lithuanian (3) 3
Portuguese (3) 3
Slovak (3) 3
Bulgarian (1) 1
Finnish (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Food and Function, ISSN 2042-6496, 12/2014, Volume 6, Issue 1, pp. 296 - 33
Beneficial effects of green tea ( Camellia sinensis , Theaceae) extracts against obesity have been reported; however, the anti-obesity ability of the major... 
SUPPLEMENTATION | OXIDATION | BODY-FAT | OBESITY | LIPID-METABOLISM | BIOCHEMISTRY & MOLECULAR BIOLOGY | FOOD SCIENCE & TECHNOLOGY | THEANINE | EPIGALLOCATECHIN GALLATE | CATECHINS | ANTIOXIDANT PROPERTIES | EXTRACT | Camellia sinensis - chemistry | Liver - pathology | Adipose Tissue, White - immunology | Obesity - immunology | Male | Obesity - blood | Anti-Obesity Agents - therapeutic use | Dietary Supplements - analysis | Liver - immunology | Polysaccharides - administration & dosage | Hypolipidemic Agents - chemistry | Polysaccharides - therapeutic use | Hypolipidemic Agents - analysis | Anti-Obesity Agents - administration & dosage | Specific Pathogen-Free Organisms | Anti-Inflammatory Agents, Non-Steroidal - analysis | Plant Extracts - isolation & purification | Random Allocation | Hyperlipidemias - prevention & control | Rats, Sprague-Dawley | Obesity - pathology | Anti-Obesity Agents - chemistry | Obesity - prevention & control | Polyphenols - analysis | Hypolipidemic Agents - therapeutic use | Polyphenols - therapeutic use | Plant Extracts - therapeutic use | Leptin - antagonists & inhibitors | Plant Extracts - chemistry | Caffeine - analysis | Caffeine - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - chemistry | Anti-Obesity Agents - analysis | Plant Extracts - administration & dosage | Leptin - blood | Caffeine - therapeutic use | Polysaccharides - isolation & purification | Food Handling | Cytokines - blood | Plant Leaves - chemistry | Adipose Tissue, White - pathology | Polyphenols - isolation & purification | Polysaccharides - analysis | Caffeine - isolation & purification | Animals | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Hyperlipidemias - etiology | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Hypolipidemic Agents - administration & dosage | Cytokines - antagonists & inhibitors | Polyphenols - administration & dosage | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2014, Volume 371, Issue 3, pp. 203 - 212
Adults with vascular disease were treated with a statin to lower LDL cholesterol and were assigned to receive either extended-release niacin plus laropiprant... 
NICOTINIC-ACID | LDL CHOLESTEROL | MEDICINE, GENERAL & INTERNAL | METABOLIC SYNDROME | MYOCARDIAL-INFARCTION | RANDOMIZED-TRIALS | EFFICACY | SAFETY | PLACEBO-CONTROLLED TRIAL | NIACIN/LAROPIPRANT | DYSLIPIDEMIA | Follow-Up Studies | Humans | Middle Aged | Male | Hypercholesterolemia - drug therapy | Indoles - administration & dosage | Infection - chemically induced | Niacin - administration & dosage | Treatment Failure | Musculoskeletal Diseases - chemically induced | Niacin - adverse effects | Cholesterol, LDL - blood | Female | Hypolipidemic Agents - adverse effects | Atherosclerosis - drug therapy | Double-Blind Method | Risk Factors | Indoles - adverse effects | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Hypolipidemic Agents - administration & dosage | Diabetes Mellitus - chemically induced | Aged | Hemorrhage - chemically induced | Delayed-Action Preparations | Drug Combinations | Dose-response relationship (Biochemistry) | Laropiprant | Blood circulation disorders | Care and treatment | Dosage and administration | Niacin | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | Heart attacks | Risk groups | Diabetes mellitus | Cardiovascular disease | Low density lipoprotein | Cholesterol | Musculoskeletal system | Vascular diseases | Arteriosclerosis | Vitamin B | Skin | Lipoproteins (high density) | Drug dosages | Statins | Index Medicus | Abridged Index Medicus
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9784, pp. 2181 - 2192
Summary Background Lowering LDL cholesterol with statin regimens reduces the risk of myocardial infarction, ischaemic stroke, and the need for coronary... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | UNITED-KINGDOM HEART | DESIGN | METAANALYSIS | REQUIRING PROLONGED OBSERVATION | EFFICACY | CARDIOVASCULAR EVENTS | SAFETY | HEMODIALYSIS | OUTCOMES | PARTICIPANTS | Confidence Intervals | Simvastatin - adverse effects | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Ezetimibe | Renal Dialysis - methods | Male | Reference Values | Cholesterol, LDL - analysis | Kidney Function Tests | Renal Insufficiency, Chronic - drug therapy | Dose-Response Relationship, Drug | Renal Insufficiency, Chronic - therapy | Renal Dialysis - mortality | Time Factors | Renal Insufficiency, Chronic - mortality | Adult | Female | Renal Insufficiency, Chronic - diagnosis | Drug Therapy, Combination | Severity of Illness Index | Hypolipidemic Agents - adverse effects | Double-Blind Method | Drug Administration Schedule | Risk Assessment | Simvastatin - administration & dosage | Cholesterol, LDL - drug effects | Treatment Outcome | Azetidines - administration & dosage | Hypolipidemic Agents - administration & dosage | Survival Analysis | Aged | Simvastatin | Low density lipoproteins | Physiological aspects | Drug therapy, Combination | Research | Kidney diseases | Diagnosis | Drug therapy | Health aspects | Studies | Heart failure | Cardiac arrhythmia | Medical imaging | Hospitals | Compliance | Cardiovascular disease | Blood pressure | Family medical history | Cholesterol | Cancer | Index Medicus | Abridged Index Medicus | Mortality | myocardial infarction | cholesterol | councils | Dialysis | medical research | stroke | Kidney | Fast track | Pharmaceutical Sciences | Basic Medicine | PHARMACY | Medical and Health Sciences | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper | FARMACI | Farmaceutiska vetenskaper
Journal Article